Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

The tenosynovial giant cell tumor (TGCT) trial hit its primary endpoint, teeing up an option decision that could establish ...

Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), reducing the price ...

Pharmaceutical giant Merck (NYSE: MRK) is recognized for its extensive product portfolio of more than 52 drugs covering categories like vaccines, hospital acute care, cardiology, virology ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Merck & Company (MRK – Research Report), ...

You must continuously monitor what's going on in your line to ensure that you have product quality ... to remove liquid ...